Works by Britten, Carolyn D.

Results: 11

Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 97, doi. 10.1007/s00280-007-0579-4

By:

Guo, Feng;
Letrent, Stephen P.;
Munster, Pamela;
Britten, Carolyn D.;
Gelmon, Karen;
Tolcher, Anthony W.;
Sharma, Amarnath

Publication type:

Article

A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 515, doi. 10.1007/s00280-007-0498-4

By:

Britten, Carolyn D.;
Kabbinavar, Fairooz;
Hecht, J. Randolph;
Bello, Carlo L.;
Li, Jim;
Baum, Charles;
Slamon, Dennis

Publication type:

Article

Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients.

Published in:

2017

By:

Wallace, Kristin;
DeToma, Allan;
Lewin, David N.;
Sun, Shaoli;
Rockey, Don;
Britten, Carolyn D.;
Wu, Jennifer D.;
Ba, Aissatou;
Alberg, Anthony J.;
Hill, Elizabeth G.

Publication type:

journal article

Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.

Published in:

Liver International, 2009, v. 29, n. 2, p. 284, doi. 10.1111/j.1478-3231.2008.01762.x

By:

Finn, Richard S.;
Bentley, Greg;
Britten, Carolyn D.;
Amado, Rafael;
Busuttil, Ronald W.

Publication type:

Article

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.

Published in:

2018

By:

Rodon, Jordi;
Pérez-Fidalgo, Alejandro;
Krop, Ian E.;
Burris, Howard;
Guerrero-Zotano, Angel;
Britten, Carolyn D.;
Becerra, Carlos;
Schellens, Jan;
Richards, Donald A.;
Schuler, Martin;
Abu-Khalaf, Maysa;
Johnson, Faye M.;
Ranson, Malcolm;
Edenfield, Jeff;
Silva, Antonio P.;
Hackl, Wolfgang;
Quadt, Cornelia;
Demanse, David;
Duval, Vincent;
Baselga, Jose

Publication type:

journal article

The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1291, doi. 10.1111/bcp.14508

By:

Pooler, Darcy B.;
Ness, Dylan B.;
Sarantopoulos, John;
Squittieri, Nicholas;
Ravichandran, Shoba;
Britten, Carolyn D.;
Amaravadi, Ravi K.;
Vaishampayan, Ulka;
LoRusso, Patricia;
Shapiro, Geoffrey I.;
Olszanski, Anthony J.;
Perez, Raymond;
Gutierrez, Martin;
O'Rourke, Mark Allen;
Chung, Vincent;
Lee, James J.;
Lewis, Lionel D.

Publication type:

Article

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin's Lymphoma or Multiple Myeloma.

Published in:

Clinical Pharmacokinetics, 2009, v. 48, n. 3, p. 199, doi. 10.2165/00003088-200948030-00006

By:

Quinn, David I.;
Nemunaitis, John;
Fuloria, Jyotsna;
Britten, Carolyn D.;
Gabrail, Nashat;
Yee, Lorrin;
Acharya, Milin;
Kai Chan;
Cohen, Nadine;
Dudov, Assen

Publication type:

Article

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.

Published in:

Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0459-2

By:

Mehrotra, Shikhar;
Britten, Carolyn D.;
Chin, Steve;
Garrett-Mayer, Elizabeth;
Cloud, Colleen A.;
Mingli Li;
Scurti, Gina;
Salem, Mohamed L.;
Nelson, Michelle H.;
Thomas, Melanie B.;
Paulos, Chrystal M.;
Salazar, Andres M.;
Nishimura, Michael I.;
Rubinstein, Mark P.;
Zihai Li;
Cole, David J.

Publication type:

Article

A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody–drug conjugate, in patients with advanced or metastatic cancer.

Published in:

Investigational New Drugs, 2021, v. 39, n. 6, p. 1613, doi. 10.1007/s10637-021-01146-x

By:

Kollmannsberger, Christian;
Britten, Carolyn D.;
Olszanski, Anthony J.;
Walker, Joan Andrews;
Zang, Wei;
Willard, Melinda D.;
Radtke, David B.;
Farrington, Daphne L.;
Bell-McGuinn, Katherine M.;
Patnaik, Amita

Publication type:

Article

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.

Published in:

Investigational New Drugs, 2020, v. 38, n. 3, p. 800, doi. 10.1007/s10637-019-00830-3

By:

Noel, Marcus;
O'Reilly, Eileen M.;
Wolpin, Brian M.;
Ryan, David P.;
Bullock, Andrea J.;
Britten, Carolyn D.;
Linehan, David C.;
Belt, Brian A.;
Gamelin, Eric C.;
Ganguly, Bishu;
Yin, Donghua;
Joh, Tenshang;
Jacobs, Ira A.;
Taylor, Carrie T.;
Lowery, Maeve A.

Publication type:

Article

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer.

Published in:

2017

By:

Wainberg, Zev;
Alsina, Maria;
Soares, Heloisa;
Braña, Irene;
Britten, Carolyn;
Conte, Gianluca;
Ezeh, Patrick;
Houk, Brett;
Kern, Kenneth;
Leong, Stephen;
Pathan, Nuzhat;
Pierce, Kristen;
Siu, Lillian;
Vermette, Jennifer;
Tabernero, Josep;
Wainberg, Zev A;
Soares, Heloisa P;
Braña, Irene;
Britten, Carolyn D;
Del Conte, Gianluca

Publication type:

journal article